TEANECK, N.J., March 16, 2012 /PRNewswire/ -- Herborium
Group, Inc. (HBRM.PK) announced today that it will make a major
announcement on April 6, 2012
regarding its business 2012 expansion and new revenue streams
through adding new Market Venture to Herborium Group, Inc.
This new venture with over $150
billion market potential may be regarded as one of the most
significant developments in the Company's history and is
expected to have a defining impact on its growth.
Dr Agnes Olszewski, CEO of
Herborium Group, Inc. stated: "we are very excited to confirm that
the Company is getting geared up for expansion in all avenues of
our products with substantial new revenue streams and
new markets ventures soon in place. We understand the
importance of natural approach to both health and quality of life
issues and our initiative has always been and always will
focus on the world of Natural Medicine, Wellness and Quality of
Life products which have been growing at an unprecedented
pace. The Company is now ready for significant growth."
About Herborium Group, Inc.
Herborium Group, Inc., a Botanical Therapeutics® company,
focuses on developing, licensing, and marketing proprietary,
botanical based medicinal products to consumers and healthcare
professionals. The Company uses clinical validation to
establish and maintain a differential advantage. The company sales
its products in the US and Europe.
For more information, please visit www.herborium.com and
www.acnease.com.
One of our most important responsibilities is to communicate
with shareholders in an open and direct manner. Comments are
based on current management expectations, and are considered
"forward-looking statements," generally preceded by words such as
"plans," "expects," "believes," "anticipates," or "intends."
We cannot promise future returns. Our statements reflect our
best judgment at the time, and we disclaim any obligation to update
or alter forward-looking statements as the result of new
information or future events. The Company urges
investors to review the risks and uncertainties contained within
its filings with the OTC Markets and/or Securities and Exchange
Commission.
For more information please inquire:
Investorsrelations@herborium.com
SOURCE Herborium Group, Inc.
